Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.5.5 entry was added along with updated dates (2026-05-18, 2026-06-01, 2027-02-01). Older entries corresponding to Revision: v3.5.4 and dates like 2025-05-15 and 2025-05-14 were removed from the study record dates.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), indicating a minor update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s interface release/version stamp is updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a software/template update without changing the underlying trial information.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.0 added; v3.4.3 removed.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.